Cart
sales@molnova.com
HCV-IN-29
CAS No. 1009119-83-8
HCV-IN-29( —— )
Catalog No. M26245 CAS No. 1009119-83-8
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 63 | Get Quote |
|
| 25MG | 103 | Get Quote |
|
| 50MG | 150 | Get Quote |
|
| 100MG | 223 | Get Quote |
|
| 500MG | 482 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHCV-IN-29
-
NoteResearch use only, not for human use.
-
Brief DescriptionHCV-IN-29 is a hepatitis C virus (HCV) inhibitor.
-
DescriptionHCV-IN-29 is a hepatitis C virus (HCV) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorTRα| TRβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1009119-83-8
-
Formula Weight570.38
-
Molecular FormulaC26H32Cl4N6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (87.66 mM)
-
SMILES[H][C@]1(CCCN1)C2=NC=C(C3=CC=C(C4=CC=C(C5=CN=C([C@]6([H])CCCN6)N5)C=C4)C=C3)N2.Cl.Cl.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pennock GD, et al. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther. 1992 Oct;263(1):163-9.
molnova catalog
related products
-
GSK-2336805
GSK-2336805 (JNJ-56914845) is a novel potent HCV NS5A inhibitor with multigenotype activity.
-
Sofosbuvir impurity ...
Sofosbuvir impurity F is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
-
MK-3281
MK-3281 is a potent and orally bioavailable inhibitor of HCV NS5B polymerase with IC50 of 6 nM; MK-3281 is an equally potent inhibitor of gt 1a (EC50=28 nM), 1b BK (EC50=9 nM), and 3a (EC50=37 nM) replicons.
